Geoffrey A. Kerchner

Affiliations: 
University of California, San Francisco, San Francisco, CA 
 Stanford University, Palo Alto, CA 
Area:
Neurology and Neurological Sciences
Google:
"Geoffrey Kerchner"
Mean distance: 12.78 (cluster 6)
 
SNBCP

Parents

Sign in to add mentor
David P. Corey research assistant 1992-1994 Harvard Medical School/ MGH
Min Zhuo grad student 1999-2003 Washington University
 (Presynaptic kainate receptors in the spinal cord dorsal horn.)
Roger A. Nicoll post-doc 2007- UCSF
Bruce L. Miller post-doc 2008-2009 UCSF

Collaborators

Sign in to add collaborator
Anthony D. Wagner collaborator 2010- UCSF
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine
Ayalon G, Lee SH, Adolfsson O, et al. (2021) Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease. Science Translational Medicine. 13
Trelle AN, Carr VA, Wilson EN, et al. (2021) Association of CSF Biomarkers with Hippocampal-dependent Memory in Preclinical Alzheimer Disease. Neurology
Kerchner GA, Filippi M. (2020) Aβ-PET pathology accumulation index: Ready for the clinic? Neurology
Trelle AN, Carr VA, Guerin SA, et al. (2020) Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adults. Elife. 9
Poston KL, Ua Cruadhlaoich MAI, Santoso LF, et al. (2020) Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study. Journal of Parkinson's Disease. 10: 591-604
Trelle AN, Carr VA, Guerin SA, et al. (2020) Author response: Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adults Elife
Blennow K, Chen C, Cicognola C, et al. (2019) Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology. Brain : a Journal of Neurology
Klein G, Delmar P, Voyle N, et al. (2019) Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis. Alzheimer's Research & Therapy. 11: 101
Teng E, Ward M, Manser PT, et al. (2019) Cross-sectional associations between [F]GTP1 tau PET and cognition in Alzheimer's disease. Neurobiology of Aging. 81: 138-145
See more...